Among Malaysians, a recent cross-sectional study in a high CVD risk cohort (patients with obstructive sleep apnea) found 3.5-fold higher Lp(a) levels in patients with NAFLD compared with those without NAFLD [170]. This evidence concerns the gene LPA and metabolic dysfunction-associated steatotic liver disease.